Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

Varde Bio ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 2.8% 2.8%   Bankruptcy risk   1.1% 1.4% 3.1% 2.4% 2.7% 2.9% 6.6% 6.2%   Credit score (0-100)   86 80 57 62 60 58 36 38   Credit rating   A A BBB BBB BBB BBB BBB BBB   Credit limit (kDKK)   192.8 38.0 0.0 0.0 0.0 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   1,701 1,478 1,297 1,466 1,205 1,073 0.0 0.0   EBITDA   716 477 269 488 62.4 -50.8 0.0 0.0   EBIT   382 147 -44.0 261 -150 -257 0.0 0.0   Pre-tax profit (PTP)   344.3 140.0 -103.6 68.4 -111.0 -267.4 0.0 0.0   Net earnings   268.7 109.4 -94.1 5.0 -81.8 -209.2 0.0 0.0   Pre-tax profit without non-rec. items   344 140 -104 68.4 -111 -267 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   5,203 4,960 4,734 4,626 4,516 4,410 0.0 0.0   Shareholders equity total   3,805 3,807 3,653 3,725 3,494 3,168 2,996 2,996   Interest-bearing liabilities   1,310 1,077 895 772 1,092 1,119 0.0 0.0   Balance sheet total (assets)   6,764 6,407 6,377 6,584 6,417 5,825 2,996 2,996   Net Debt   659 843 601 686 1,081 1,076 -2,856 -2,856     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   1,701 1,478 1,297 1,466 1,205 1,073 0.0 0.0   Gross profit growth   27.1% -13.1% -12.3% 13.1% -17.8% -11.0% -100.0% 0.0%   Employees   2 2 2 2 2 2 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   6,764 6,407 6,377 6,584 6,417 5,825 2,996 2,996   Balance sheet change%   5.0% -5.3% -0.5% 3.3% -2.5% -9.2% -48.6% 0.0%   Added value   715.8 477.2 269.0 487.7 77.3 -50.8 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -646 -644 -609 -405 -392 -382 -4,410 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   3.0 4.0 -1.0 1.0 -1.0 -2.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   22.5% 10.0% -3.4% 17.8% -12.4% -23.9% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   5.9% 2.6% -1.2% 1.2% -1.2% -3.5% 0.0% 0.0%   ROI %   6.5% 2.9% -1.4% 1.5% -1.4% -4.2% 0.0% 0.0%   ROE %   7.2% 2.9% -2.5% 0.1% -2.3% -6.3% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   56.3% 59.4% 57.3% 56.6% 54.5% 54.4% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   92.0% 176.6% 223.6% 140.6% 1,731.9% -2,117.9% 0.0% 0.0%   Gearing %   34.4% 28.3% 24.5% 20.7% 31.3% 35.3% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   3.1% 2.4% 2.8% 1.5% 3.8% 4.9% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   1.0 1.1 1.0 1.0 0.9 0.7 0.0 0.0   Current Ratio   1.0 1.1 1.0 1.0 0.9 0.7 0.0 0.0   Cash and cash equivalent   651.0 234.3 293.3 85.8 11.0 42.9 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   -17.3 89.8 32.2 53.9 -208.1 -596.7 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   358 239 135 244 39 -25 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   358 239 135 244 31 -25 0 0   EBIT / employee   191 74 -22 130 -75 -128 0 0   Net earnings / employee   134 55 -47 2 -41 -105 0 0